Evoke Pharma (EVOK) Misses Q1 EPS by 51c

Evoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.51). Revenue for the quarter came in at $3.1 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
• Morgan Stanley Downgrades Nordea Bank Abp (NDA:SS) (NRDBY) to Equalweight
• Morgan Stanley Upgrades DNB ASA (DNB:NO) (DNHBY) to Equalweight